Ethyl hydrogen (4-{[4-({2-(diethylcarbamoyl)-4-[1-(3-hydroxypropyl)-1H-pyrazol-4-yl]phenyl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonate → Ethyl hydrogen (4-{[4-({6-[1-(3-hydroxypropyl)-3-methoxy-1H-pyrazol-4-yl]-2-(methylcarbamoyl)pyridin-3-yl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonate

HRID 2279841Notes

Reaction equation

HRID 2279841 reaction equation
C(N(CC)C(C1C=C(C2C=NN(CCCO)C=2)C=CC=1NC1C(C(F)(F)F)=CN=C(NC2C=CC(CP(=O)(O)OCC)=CC=2OC)N=1)=O)C.[OH:50][CH2:51][CH2:52][CH2:53][N:54]1[CH:58]=[C:57]([C:59]2[N:64]=[C:63]([C:65](=[O:68])[NH:66][CH3:67])[C:62]([NH:69][C:70]3[C:75]([C:76]([F:79])([F:78])[F:77])=[CH:74][N:73]=[C:72]([NH:80][C:81]4[CH:95]=[CH:94][C:84]([CH2:85][P:86](=[O:93])([O:90]CC)[O:87][CH2:88][CH3:89])=[CH:83][C:82]=4[O:96][CH3:97])[N:71]=3)=[CH:61][CH:60]=2)[C:56]([O:98][CH3:99])=[N:55]1>>[OH:50][CH2:51][CH2:52][CH2:53][N:54]1[CH:58]=[C:57]([C:59]2[N:64]=[C:63]([C:65](=[O:68])[NH:66][CH3:67])[C:62]([NH:69][C:70]3[C:75]([C:76]([F:77])([F:78])[F:79])=[CH:74][N:73]=[C:72]([NH:80][C:81]4[CH:95]=[CH:94][C:84]([CH2:85][P:86](=[O:90])([OH:93])[O:87][CH2:88][CH3:89])=[CH:83][C:82]=4[O:96][CH3:97])[N:71]=3)=[CH:61][CH:60]=2)[C:56]([O:98][CH3:99])=[N:55]1

Participants

3

Reactant 2

HCID 86697678Ethyl hydrogen (4-{[4-({2-(diethylcarbamoyl)-4-[1-(3-hydroxypropyl)-1H-pyrazol-4-yl]phenyl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonateHCID 86697779diethyl (4-{[4-({6-[1-(3-hydroxypropyl)-3-methoxy-1H-pyrazol-4-yl]-2-(methylcarbamoyl)pyridin-3-yl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonate2×

Product 1

HCID 86697778Ethyl hydrogen (4-{[4-({6-[1-(3-hydroxypropyl)-3-methoxy-1H-pyrazol-4-yl]-2-(methylcarbamoyl)pyridin-3-yl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonateYield 48.1%

Procedure

Prepared analogously to Compound 3A using diethyl (4-{[4-({6-[1-(3-hydroxypropyl)-3-methoxy-1H-pyrazol-4-yl]-2-(methylcarbamoyl)pyridin-3-yl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonate (Compound 48B, 286 mg, 0.395 mmol) affording 132 mg of the title compound (48%). 1H NMR (400 MHz, CD3OD) δ 8.86 (br. s., 1H), 8.29 (br. s., 2H), 7.63-7.77 (m, 2H), 7.12 (s, 1H), 6.88 (d, J=8.1 Hz, 1H), 4.14 (t, J=6.7 Hz, 2H), 4.07 (s, 3H), 3.80-3.90 (m, 5H), 3.59 (t, J=6.1 Hz, 2H), 2.99-3.08 (m, 2H), 2.96 (s, 3H), 2.07 (quin, J=6.4 Hz, 2H), 1.17 (t, J=7.1 Hz, 3H). MS (ESI): m/z=695.56 [M+H]+. UPLC: tR=1.15 min (UPLC-TOF: polar—2 min).

Sources & evidence

ORD record
ord-5154f8617c8c49ee842a4d1821374574
Source dataset
uspto-grants-2015_09
Patent number
US09133224B2

Reaction notes

Loading…